Clear Search sequence regions


  • adult (1)
  • cd4 count (2)
  • child (1)
  • female (1)
  • hiv status (1)
  • humans (1)
  • lymphoid hyperplasia (1)
  • masses (6)
  • patients (9)
  • young adult (1)
  • Sizes of these terms reflect their relevance to your search.

    The aim of this study was to compare the histology of nasopharyngeal masses of HIV positive and HIV negative patients and to determine the prevalence of malignancy in nasopharyngeal masses in HIV positive patients. The records of all patients who had nasopharyngeal biopsies performed at the Department of Otorhinolaryngology, Universitas Academic Hospital between January 2006 and December 2011, were reviewed and 151 patients were identified. The HIV status of 110 of these patients was known: 78 (70.9 %) were HIV positive and 32 (29.1 %) were HIV negative. The CD4 count was known in 63 (80.8 %) of the HIV positive patients with the median CD4 count being 275 cells/μl (14-712 cells/μl). Most nasopharyngeal masses in HIV positive patients were benign. Malignancies were significantly more common in the HIV negative group than in the HIV positive group, with six (7.7 %) of the nasopharyngeal masses in the HIV positive group being malignant, while eight (25 %) of those in the HIV negative group were malignant. Most nasopharyngeal masses in HIV positive patients are due to lymphoid hyperplasia. The presence of large cervical lymphadenopathy should alert one to the possibility of a malignancy rather than a benign disease process.

    Citation

    T Erasmus, T Daniller, J Goedhals, G Joubert, R Y Seedat. The histology of nasopharyngeal masses: a comparison between HIV positive and HIV negative patients. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2013 Feb;270(2):755-9

    Expand section icon Mesh Tags


    PMID: 23053374

    View Full Text